Medindia

X

Alsius Corporation Awarded Three-Year Agreement with HealthTrust Purchasing Group

Friday, May 23, 2008 General News J E 4
Advertisement
IRVINE, Calif., May 22 Alsius Corporation(Nasdaq: ALUS), the worldwide leader in intravascular temperature management(IVTM(TM)) therapies for critically ill patients, was awarded a three-yearcontract with HealthTrust Purchasing Group, LP (HealthTrust) to provideintravascular temperature management products to the group purchasingorganization's (GPO) extensive network of over 1,400 not-for-profit andfor-profit acute care hospitals.

"This is the fourth contract we have been awarded by a major hospital GPOin the U.S.," said Bill Worthen, president and chief executive officer ofAlsius. "We are pleased that our intravascular temperature management solutionwas chosen by HealthTrust and we look forward to working together to introduceour product offerings to its members."

About Alsius IVTM(TM)

Alsius IVTM consists of the CoolGard 3000(R), Thermogard(TM) andThermogard XP(TM) systems and a family of single-use catheters, including theCool Line(R), Icy(R), Fortius(R) and Quattro(TM) catheters. The catheters areinserted into a major vein through a patient's neck or groin, and circulatecool or warm saline in a closed-loop through balloons that surround thecatheters. This approach decreases or increases core temperature from theinside of the body out toward the exterior, allowing for significantly morerapid control of a patient's core body temperature, with greater efficiencyand precision, compared to conventional external temperature managementproducts such as cooling and warming blankets and ice packs.

About Alsius Corporation

Alsius, headquartered in Irvine, Calif., is a medical device company thatdevelops, manufactures and sells proprietary products to precisely controlpatient temperature in hospital critical care settings. Controlling bodytemperature, through cooling and warming, is becoming the standard of care forpatients in select critical conditions and those undergoing a variety ofsurgical procedures. Alsius markets a comprehensive suite of catheter-basedintravascular temperature management products that address the need foreffective, accurate, easy-to-use and cost-effective control of bodytemperature in critical care patients. For more information, visithttp://www.alsius.com.

About HealthTrust Purchasing Group, LP

HealthTrust Purchasing Group, headquartered in Brentwood, Tennessee, is agroup purchasing organization that supports over 1,400 not-for-profit andfor-profit acute care facilities, as well as ambulatory surgery centers,physician practices, and alternate care sites. With an annual purchasingvolume by its members of more than $13 billion, HealthTrust is committed toobtaining the best price for clinically-recommended products, ensuring theirtimely delivery and continuously evaluating and improving its services to thepatients, physicians and clinicians it serves. HealthTrust is located at 155Franklin Road, Suite 400, Brentwood, TN 37027, Website:http://www.healthtrustpg.com.

Safe Harbor

This press release may contain statements regarding plans and expectationsfor the future that constitute forward-looking statements within the meaningof the Private Securities Litigation Reform Act of 1995. All statements otherthan statements of historical fact are forward-looking. Such forward lookingstatements, based upon the current beliefs and expectations of Alsius'management, are subject to risks and uncertainties, which could cause actualresults to differ materially from those described in the forward-lookingstatements. The information set forth herein should be read in light of suchrisks. Additional information concerning such risks and uncertainties arecontained in Alsius' filings with the Securities and Exchange Commission,which can be accessed electronically on the Securities and Exchange Commissionwebsite at http://www.sec.gov.

SOURCE Alsius Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
NutraCea Announces USDA Approval of the Use of Sta...
S
Bharatt Chowrira Joins Nektar Therapeutics as Chie...